Stryker (NYSE:SYK) Q4 results:
Sales: $4,131M (+8.8%); Orthopedics: $1,467M (+6.7%); MedSurg: $1,837M (+6.8%); Neurotech and Spine: $827M (+18.0%).
Net income: $725M (-64.9%); non-GAAP net income: $948M(+14.5%); EPS: $1.90 (-65.1%); non-GAAP EPS: $2.49 (+14.2%).
Cash flow ops (full year): $2,191M (-16.1%).
Q1 guidance: Non-GAAP EPS: $2.05 – 2.10.
2020 guidance: Sales growth: 6.5 – 7.5%; non-GAAP EPS: $9.00 – 9.20.
https://seekingalpha.com/news/3535431-stryker-q4-non-gaap-earnings-up-15
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.